These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12101773)

  • 21. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of oncogenes and tumor suppressor genes in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene.
    Qin G; Meng Z
    Inhal Toxicol; 2010 Mar; 22(4):322-9. PubMed ID: 20064080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Topics on gene abnormality in endometrial cancer].
    Shiozawa T; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():259-63. PubMed ID: 15535247
    [No Abstract]   [Full Text] [Related]  

  • 24. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of tumor suppressor genes p16, p21 and p53 in a pair of lung adenocarcinoma cell lines with different metastasis potentials: Anip973 and AGZY83-a].
    Wang B; Yan C; Wu Y; Gao H; Wang Q; Jin Y; Huang C; Zhang G; Fu S; Li P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):128-31. PubMed ID: 11295133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular pathogenesis of lung cancer].
    Osada H; Takahashi T
    Nihon Rinsho; 2000 May; 58(5):1012-6. PubMed ID: 10824541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene.
    Patel SD; Tran AC; Ge Y; Moskalenko M; Tsui L; Banik G; Tom W; Scott M; Chen L; Van Roey M; Rivkin M; Mendez M; Gyuris J; McArthur JG
    Mol Ther; 2000 Aug; 2(2):161-9. PubMed ID: 10947944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
    Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular genetics of lung cancer.
    Carbone DP; Minna JD
    Adv Intern Med; 1992; 37():153-71. PubMed ID: 1348393
    [No Abstract]   [Full Text] [Related]  

  • 32. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C; Bhavani K; Chisari FV
    Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
    Schneider PM; Praeuer HW; Stoeltzing O; Boehm J; Manning J; Metzger R; Fink U; Wegerer S; Hoelscher AH; Roth JA
    Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cell cycle and breast cancer].
    Puisieux A
    Ann Pathol; 2000; 20 Suppl():S6-12. PubMed ID: 11261299
    [No Abstract]   [Full Text] [Related]  

  • 38. Oncogenes in tumors of gallbladder and biliary tract.
    Enjoji M; Nakamuta M; Nawata H
    Fukuoka Igaku Zasshi; 2004 Feb; 95(2):31-5. PubMed ID: 15101197
    [No Abstract]   [Full Text] [Related]  

  • 39. [Deregulation of cell cycle control in lung cancer].
    Toyoshima H
    Nihon Rinsho; 2000 May; 58(5):1031-5. PubMed ID: 10824544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetics of bladder cancer: pathways of development and progression.
    Knowles MA
    Cancer Surv; 1998; 31():49-76. PubMed ID: 15281317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.